Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Amendment (Definition of Booster Dose) Determination 2022
I, Nigel Murray, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 30 March 2022
Assistant Secretary
Medical Benefits Division
Health Resourcing Group
Department of Health
Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1— Amendments
This instrument is the Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Amendment (Definition of Booster Dose) Determination 2022.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 April 2022. |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1— COVID-19 vaccine amendments
Repeal the definition, substitute:
booster dose, for any particular patient, means a dose of a COVID-19 vaccine that is not a primary dose.
primary dose, for any particular patient, means a dose in accordance with the primary schedule of a COVID-19 vaccine as set out in the guidance published by the Australian Technical Advisory Group on Immunisation (ATAGI) titled ‘ATAGI statement on defining 'up-to-date' status for COVID-19 vaccination’ as at 10 February 2022.